Early research (Phase 1)Study completedNCT03602235What this trial is testingHigh Dose Ascorbic Acid for Plasma Cell DisordersWho this might be right forMultiple Myeloma Christopher Strouse 6
Post-approval studies (Phase 4)UnknownNCT02992834What this trial is testingAnti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell LymphomaWho this might be right forLymphoma, B Cell jiangjingting 10
Not applicableUnknownNCT00977509What this trial is testingGene Mutations in Non-Small Cell Lung Cancer CellsWho this might be right forCarcinoma, Non-Small-Cell Lung National Taiwan University Hospital 200
Not applicableStudy completedNCT01844999What this trial is testingPersonal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksWho this might be right forProstate Cancer Dana-Farber Cancer Institute 392
Not applicableUnknownNCT04877899What this trial is testingMazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 ProtocolWho this might be right forCardiotoxicityCancer Ultromics Ltd 250
Testing effectiveness (Phase 2)UnknownNCT05241899What this trial is testingA Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) CancerWho this might be right forGastric Cancer The First Affiliated Hospital of Zhengzhou University 56
Testing effectiveness (Phase 2)Looking for participantsNCT07130032What this trial is testingEfficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint BlockadeWho this might be right forMetastatic Non-small Cell Lung Cancer (NSCLC)Metastatic Cutaneous Melanoma EuroCityClinic LLC 90
Not applicableStudy completedNCT05684432What this trial is testingRadiation-induced Diarrhoea During Curative EBRT of Prostate and Rectal CancerWho this might be right forRadiation-induced Diarrhoea in Prostate and Rectal Cancer Aalborg University Hospital 40
Not applicableStudy completedNCT00003598What this trial is testingUMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical NeoplasiaWho this might be right forCervical CancerPrecancerous/Nonmalignant Condition University of Michigan Rogel Cancer Center 180
Not applicableUnknownNCT04223063What this trial is testingExercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility StudyWho this might be right forBladder CancerUrothelial Carcinoma Ross Mason 20
Not applicableWithdrawnNCT05418387What this trial is testingA Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in ArizonaWho this might be right forRenal Cell CarcinomaHepatocellular Carcinoma University of Arizona
Very early researchWithdrawnNCT03591614What this trial is testingDendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering MyelomaWho this might be right forMonoclonal GammopathySmoldering MyelomaMyeloma Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT05189314What this trial is testingRFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life StudyWho this might be right forThyroid Nodules Columbia University 100
Testing effectiveness (Phase 2)Ended earlyNCT01090414What this trial is testingAn Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib StudyWho this might be right forChronic Lymphocytic LeukemiaLymphoma, Non-Hodgkin Gilead Sciences 202
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706What this trial is testingPembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Who this might be right forCarcinoma, Renal Cell Merck Sharp & Dohme LLC 1,854
Testing effectiveness (Phase 2)Study completedNCT00101816What this trial is testingDasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib MesylateWho this might be right forChronic Myeloid LeukemiaBlast Crisis Bristol-Myers Squibb 124
Testing effectiveness (Phase 2)Study completedNCT01941316What this trial is testingStudy of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer PatientsWho this might be right forSmall Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers Cancer Research and Biostatistics Clinical Trials Consortium 78
Large-scale testing (Phase 3)Looking for participantsNCT07627906What this trial is testingKetofol Versus Ketodex for POD Prophylaxis in Elderly Cancer SurgeryWho this might be right forPostoperative Delirium (POD) Cairo University 180
Testing effectiveness (Phase 2)WithdrawnNCT03991104What this trial is testingSOX-based CRT for Esophageal Cancer.Who this might be right forEsophageal Cancer Zhejiang Provincial People's Hospital
Not applicableLooking for participantsNCT07208084What this trial is testingProject SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast CancerWho this might be right forBreast Cancer University of California, Los Angeles 90